Products

EMARKETER delivers leading-edge research to clients in a variety of forms, including full-length reports and data visualizations to equip you with actionable takeaways for better business decisions.
PRO+
New data sets, deeper insights, and flexible data visualizations.
Learn More
Reports
In-depth analysis, benchmarks and shorter spotlights on digital trends.
Learn More
Forecasts
Interactive projections with 10k+ metrics on market trends, & consumer behavior.
Learn More
Charts
Proprietary data and over 3,000 third-party sources about the most important topics.
Learn More
Industry KPIs
Industry benchmarks for the most important KPIs in digital marketing, advertising, retail and ecommerce.
Learn More
Briefings
Client-only email newsletters with analysis and takeaways from the daily news.
Learn More
Analyst Access Program
Exclusive time with the thought leaders who craft our research.
Learn More

About EMARKETER

Our goal is to unlock digital opportunities for our clients with the world’s most trusted forecasts, analysis, and benchmarks. Spanning five core coverage areas and dozens of industries, our research on digital transformation is exhaustive.
Our Story
Learn more about our mission and how EMARKETER came to be.
Learn More
Methodology
Rigorous proprietary data vetting strips biases and produces superior insights.
Learn More
Our People
Take a look into our corporate culture and view our open roles.
Join the Team
Contact Us
Speak to a member of our team to learn more about EMARKETER.
Contact Us
Newsroom
See our latest press releases, news articles or download our press kit.
Learn More
Advertising & Sponsorship Opportunities
Reach an engaged audience of decision-makers.
Learn More
Events
Browse our upcoming and past events, recent podcasts, and other featured resources.
Learn More
Podcasts
Tune in to EMARKETER's daily, weekly, and monthly podcasts.
Learn More

Cigna wants to invest $450M in digital health startups—here’s where we think it’ll target its spending

The news: Cigna plans to pour $450 million into its VC arm (Cigna Ventures) to invest in digital health tools and care delivery, with an emphasis on investing in early stage companies, per a recent Cigna press release.

More on Cigna Ventures: This isn’t the first time Cigna allocated funds to digital health investments.

  • In 2018, the massive insurer contributed $250 million to its VC arm—and since then, it’s made 15 direct investments, per Cigna’s 2021 SEC report.
  • Cigna’s most recent digital health investments include startups like insurtech Bright Health, maternal care startup Babyscript, digital musculoskeletal (MSK) company RecoveryOne, and kidney care provider Cricket Health.

Cigna is focused on cutting costs: The legacy insurer’s positive ROI from investments like digital musculoskeletal treatment startup RecoveryOne is likely fueling its ongoing interest in digital health innovations.

For example, earlier this year, RecoveryOne said it was expanding its partnership with its Cigna after the digital MSK entrant was able to reduce pain diagnoses for Cigna members.

  • Based on data from 350,000 Cigna members, RecoveryOne says it saved the insurer $751 per member per month for MSK-related diagnoses and reduced costs by nearly 77% for low back pain and 84% for rotator cuff tears.
  • Early intervention through digital platforms like RevoveryOne (which offers virtual physical therapy) could prevent chronic pain from worsening, saving insurers like Cigna on costly surgeries.

What’s next? We suspect Cigna will leverage its VC arms to dive deeper into home healthcare investments as it preps for rising senior-related costs—and to stay on par with its competitors’ digital health innovation.

As more boomers age into Medicare over the next few years, there will be an influx of Medicare Advantage (MA) members.

  • The number of MA enrollees swelled from over 10 million in 2010 to over 23 million in 2020 alone, per KFF data.

As a result, insurers like Humana and UnitedHealth Group (UHG) are quietly pumping cash into home health companies to get members care in between doctors’ visits and prevent expensive readmissions.

Optum Ventures (UHG’s VC fund) and Humana are both investors in home healthcare entrant Dispatch Health, for instance.

But out of its 15 investments, Cigna has yet to make an investment in home healthcare. This means that could be the insurer’s next target in a play to cut costs and keep up with Humana and UHG’s home health tech.

  • Cigna's potential interest in home health would be good news for digital health startups seeking to woo payers. In fact, it wouldn’t be surprising if startups like home health software company AlayaCare or hospital at home startup Contessa scored the attention of Cigna next.